Kaiser P - Search Results

1

Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study.

Liu K, Wang H, He W, Ye J, Song Y, Wang Y, Liu X, Wu Z, Chen S, Fan K, Liu Y, Zhang F, Li Z, Liu L, Zhang J, Zhang X, Ye J, Liang X, Li X, Ke X, Wu Q, Li J, Tao S, Wang X, Rosenfeld P, Heier JS, Kaiser P, Xu X. Liu K, et al. Among authors: kaiser p. Br J Ophthalmol. 2022 Oct;106(10):1436-1443. doi: 10.1136/bjophthalmol-2020-318690. Epub 2021 May 17. Br J Ophthalmol. 2022. PMID: 34001667 Free PMC article. Clinical Trial.

2

A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration.

Nguyen QD, Shah SM, Browning DJ, Hudson H, Sonkin P, Hariprasad SM, Kaiser P, Slakter JS, Haller J, Do DV, Mieler WF, Chu K, Yang K, Ingerman A, Vitti RL, Berliner AJ, Cedarbaum JM, Campochiaro PA. Nguyen QD, et al. Among authors: kaiser p. Ophthalmology. 2009 Nov;116(11):2141-8.e1. doi: 10.1016/j.ophtha.2009.04.030. Epub 2009 Aug 22. Ophthalmology. 2009. PMID: 19700196 Clinical Trial.

3

Phase 1 dose-escalation study of a siRNA targeting the RTP801 gene in age-related macular degeneration patients.

Nguyen QD, Schachar RA, Nduaka CI, Sperling M, Basile AS, Klamerus KJ, Chi-Burris K, Yan E, Paggiarino DA, Rosenblatt I, Khan A, Aitchison R, Erlich SS; PF-04523655 Study Group. Nguyen QD, et al. Eye (Lond). 2012 Aug;26(8):1099-105. doi: 10.1038/eye.2012.106. Epub 2012 May 25. Eye (Lond). 2012. PMID: 22627477 Free PMC article. Clinical Trial.

4

Improvement in vision-related function with intravitreal aflibercept: data from phase 3 studies in wet age-related macular degeneration.

Yuzawa M, Fujita K, Wittrup-Jensen KU, Norenberg C, Zeitz O, Adachi K, Wang EC, Heier J, Kaiser P, Chong V, Korobelnik JF. Yuzawa M, et al. Among authors: kaiser p. Ophthalmology. 2015 Mar;122(3):571-8. doi: 10.1016/j.ophtha.2014.09.024. Epub 2014 Nov 6. Ophthalmology. 2015. PMID: 25439429 Clinical Trial.

5

The 12- and 24-Month Effects of Intravitreal Ranibizumab, Aflibercept, and Bevacizumab on Intraocular Pressure: A Network Meta-Analysis.

Nanji K, Sarohia GS, Kennedy K, Ceyhan T, McKechnie T, Phillips M, Devji T, Thabane L, Kaiser P, Sarraf D, Garg SJ, Sivaprasad S, Wykoff CC, Bakri SJ, Sheidow T, Bhandari M, Chaudhary V. Nanji K, et al. Among authors: kaiser p. Ophthalmology. 2022 May;129(5):498-508. doi: 10.1016/j.ophtha.2021.11.024. Epub 2021 Dec 4. Ophthalmology. 2022. PMID: 34871637

6

Treat-and-extend regimens of anti-vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta-analysis.

Nanji K, Khan M, Khalid MF, Xie JS, Sarohia GS, Phillips M, Thabane L, Garg SJ, Kaiser P, Sivaprasad S, Wykoff CC, Chaudhary V. Nanji K, et al. Among authors: kaiser p. Acta Ophthalmol. 2022 Sep;100(6):e1199-e1208. doi: 10.1111/aos.15068. Epub 2021 Nov 29. Acta Ophthalmol. 2022. PMID: 34845830 Free article.

7

Predictors of response to a lapse in anti-VEGF treatment in patients with macular edema secondary to retinal vein occlusion.

Maatouk CM, Liu JC, Alsaloum P, Iyer AI, Kaiser PM, Singh RP, Talcott KE. Maatouk CM, et al. Among authors: kaiser pm. Can J Ophthalmol. 2023 Sep 14:S0008-4182(23)00250-8. doi: 10.1016/j.jcjo.2023.08.002. Online ahead of print. Can J Ophthalmol. 2023. PMID: 37716706

8

SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.

Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Antoszyk AN; SCORE Study Investigator Group. Scott IU, et al. Am J Ophthalmol. 2009 Nov;148(5):725-732.e7. doi: 10.1016/j.ajo.2009.06.004. Epub 2009 Aug 11. Am J Ophthalmol. 2009. PMID: 19674727 Free PMC article. Clinical Trial.

9

Retinal infiltrates secondary to metastatic squamous cell carcinoma masquerading as infectious retinitis.

Singh RP, Steinle NC, Bedi R, Kaiser P, Lowder CY. Singh RP, et al. Among authors: kaiser p. Retin Cases Brief Rep. 2014 Fall;8(4):333-5. doi: 10.1097/ICB.0000000000000062. Retin Cases Brief Rep. 2014. PMID: 25372541 Review.

10

Consequences of anti-vascular endothelial growth factor treatment lapse in patients with retinal vein occlusion.

Liu JC, Alsaloum P, Iyer AI, Kaiser PM, Singh RP. Liu JC, et al. Among authors: kaiser pm. Eye (Lond). 2023 Feb;37(3):453-458. doi: 10.1038/s41433-022-01960-4. Epub 2022 Feb 7. Eye (Lond). 2023. PMID: 35132210 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,123 results

Search Page